Solta Medical Announces Third Quarter 2011 Results Release and Conference Call - MarketWatch (press release)

Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!

HAYWARD, Calif., Oct. 18, 2011 /PRNewswire via COMTEX/ -- Solta Medical, Inc. /quotes/zigman/112998/quotes/nls/sltm SLTM +4.40% , a global leader in the medical aesthetics market, today announced that it will release its financial results for the third quarter ended September 30, 2011, after market close on Tuesday, November 1, 2011. The Company will also host a conference call and webcast on Tuesday, November 1, 2011, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results and current corporate developments, including the pending acquisition of Medicis Technologies Corporation (formerly LipoSonix, Inc.), a subsidiary of Medicis. The dial-in number for the conference call is 877-941-0843 for domestic participants and 480-629-9819 for international participants.

To access the live webcast of the call, go to Solta Medical's website at www.solta.com and click on Investor Relations. An archived webcast will also be available at www.solta.com .

About Solta Medical, Inc.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry's four premier brands: Thermage®, Fraxel®, Isolaz®, and CLARO®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz is the only laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. Since 2002, over one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com .

SOURCE Solta Medical, Inc.

Copyright (C) 2011 PR Newswire. All rights reserved

/quotes/zigman/112998/quotes/nls/sltm

Volume: 248,806

Oct. 17, 2011 4:00p

18 Oct, 2011


--
Source: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE-7c4do2SsMNu7CfhvM615fYXcdQ&url=http://www.marketwatch.com/story/solta-medical-announces-third-quarter-2011-results-release-and-conference-call-2011-10-18
~
Manage subscription | Powered by rssforward.com

What's on Your Mind...

Powered by Blogger.